The number of pharmaceutical and life science professionals using or experimenting with blockchain technology has risen to 60 percent, up from 22 percent in 2017, according to a survey by the nonprofit Pistoia Alliance.
According to a pharmaphorum report, however, 40 percent are not taking steps to deploy blockchain solutions.
The nonprofit surveyed 170 senior professionals.
Fifty-five percent of the respondents said access to blockchain-fluent personnel is a significant obstacle toward implementing the technology, with 16 percent saying it’s too complicated.
“We are currently focusing on educating scientists and researchers about the potential uses of blockchain technologies outside of the supply chain, particularly in R&D,” Richard Shute, a consultant for the Pistoia Alliance, said. “At The Pistoia Alliance, we want to support our members’ initiatives in blockchain, as well as provide a secure global forum for partnerships and collaboration.”